Axonics: Buy at the High?
Axonics (NASDAQ: AXNX) specializes in making medical devices to treat bladder and bowel dysfunction. It's the type of therapy that may be embarrassing to some, but the company's financial performance is nothing to be ashamed of.
On Monday, the stock hit its 52-week high of $74.45. Axonics' shares are up more than 49% this year. The reasons for the surge are simple: remarkable growth and the type of innovation that will support more of the same.
Image source: Getty Images.
Source Fool.com
